Skip to main content
Andrew Pieper, MD, Psychiatry, Cleveland, OH

AndrewAPieperMD

Psychiatry Cleveland, OH

Associate Professor, Psychiatry, University of Iowa Roy J. and Lucille A. Carver CO

Dr. Pieper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pieper's full profile

Already have an account?

  • Office

    210 Cornell Rod
    Cleveland, OH 44106

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Consultation-Liaison Psychiatry, 2004 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Psychiatry, 2001 - 2004
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2001

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2018 - 2026
  • IA State Medical License
    IA State Medical License 2012 - 2020
  • TX State Medical License
    TX State Medical License 2006 - 2014
  • American Board of Psychiatry and Neurology Psychiatry

Publications & Presentations

PubMed

Other

Press Mentions

  • Sildenafil as an Alzheimer’s Candidate Drug: Further Support from Insurance Database and Mechanistic Studies
    Sildenafil as an Alzheimer’s Candidate Drug: Further Support from Insurance Database and Mechanistic StudiesMarch 11th, 2024
  • Cleveland Clinic-Led Research Supports Repurposing Sildenafil (Viagra) for Alzheimer’s Treatment
    Cleveland Clinic-Led Research Supports Repurposing Sildenafil (Viagra) for Alzheimer’s TreatmentMarch 5th, 2024
  • Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Protect the Alzheimer’s Brain
    Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Protect the Alzheimer’s BrainJanuary 11th, 2023
  • Join now to see all

Grant Support

  • Discovery, Characterization And Preclinical Development Of Pro-Neurogenic DrugsNational Institute Of Mental Health2009–2012
  • In Vivo Modulation Of The IP3R By PhosphorylationNational Institute Of Mental Health1997–2000